localized prostate cancer
Conditions
Interventions
Cryosurgery
Sponsors
Department of Urology, Kyoto Prefectural University of Medicine
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Clinically significant prostate cancer proven by prostate biopsy, imaging, and biomarker 2) The targeted prostate cancer foci having three-dimensional distance of >5mm from the neurovascular bundle and external urinary sphincter 3) No distant metastasis
Exclusion criteria
Exclusion criteria: 1) Drug treatment for prostate cancer within 90 days from consented day 2) Anti-androgen therapy for BPH within 90 days from consented day 3) Difficulty of undergoing transrectal ultrasonography 4) Active cancer in other organ 5) Attending physician determines that the ineligible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of adverse event (from operative day to post-op 6-months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Control rate of clinically significant cancer (from operative day to post-op 6-months) Patient-reported quality of life (from pre-op to post-op 6-months) | — |
Countries
Japan
Contacts
Public ContactOsamu Ukimura, MD, PhD
Kyoto Prefectural University of Medicine Urology
Outcome results
None listed